Blog

    • August 19, 2019

    Capsule Pharmacy 'Dear Doctor' Interview Series: Sara Nayeem

    *Interview of Sara Nayeem by Maya De La Rosa-Cohen; originally published as part of the Capsule 'Dear Doctor' Series, which highlights women physicians working throughout the field of healthcare. Dr. Sara Nayeem was selected three times as one of GrowthCap’s Top 40 Under 40 Growth Investors. Having earned her MD and MBA simultaneously from Yale University and worked within Merrill Lynch’s Global Healthcare Group, today she uses her knowledge and experience in both medicine and business…

  • The Investor’s Dilemma: What Matters Most?

    People often ask VCs: What is the most important thing to look for in new investments? It’s a simple enough question, but the answer is actually pretty complicated. We look for disruption, and we look for impact. We look for teams and companies that are solving problems and challenging the status quo. More than anything, we look for the right people—for entrepreneurs who have a certain spark about them. Very rarely, the stars align so that all of those factors—the team, technology, and market…

    • May 6, 2019

    The Twenty Minute VC with Dayna Grayson

    Dayna Grayson recently chatted with Harry Stebbings for his latest podcast episode of The Twenty Minute VC. In the episode, they cover: 1) Path: How Dayna made her way from product design and engineering into the world of venture and came to be a Partner at NEA. 2.) Sourcing: How does Dayna approach the sourcing component of venture today? What does the deck filtering process look like to Dayna, prior to meeting? What has Dayna found works best in really building rapport in the first meetings?…

  • Tiburio: Investing in Traditional Drug Development in the Era of Big Science Platforms

    For the past ten years I have been a biopharma investor at NEA, and in that time I have witnessed the drug industry truly enter the genomic age. With technologies such as gene and mRNA therapy, gene editing, CAR-T and other cell therapies, we are living in a time of unprecedented potential (and peril, as demonstrated by Chinese researcher He Jiankui’s rogue experimentation with gene editing on two human embryos). The public markets (and in some cases, strategic acquirors) have valued these…

  • How Hiring Entrepreneurs Enabled Airbnb’s Success (and Launched a New Generation of Founders)

    When I left Airbnb last year, I was delighted to join a group as dynamic as the company itself: the Airbnb alumni. And I’ve been intrigued, though not surprised, to learn how many of those bright and creative professionals are developing their own startup concepts. After all, our time at the company trained us to do just that. Employees of one great company seeding the next generation of startups is the circle of life in Silicon Valley. It started with Fairchild Semiconductor in the 1960s,…